Optimizing Red Light-Based Photodynamic Therapy for Effective Bactericidal Action Against

Jianglan Li, Takayuki Nambu, Chao Wang, Hiroki Takigawa, Hugo Maruyama, Chiho Mashimo, Toshinori Okinaga

Abstract read

In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Fluorescence-Based In Vitro Detection of Wound-Associated Bacteria with a Handheld Imaging System.Diagnostics (Basel, Switzerland) · 2025
Article
Chlorophyllin-based Photodynamic Inactivation against Candidozyma auris planktonic cells and dynamic biofilm.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jianglan LiGraduate School of Dentistry (Bacteriology), Osaka Dental University, Hirakata 573-1121, Japan.

Takayuki NambuDepartment of Microbiology, Osaka Dental University, Hirakata 573-1121, Japan.ORCID 0000-0002-0474-1389

Chao WangCenter of Oral Implantology, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou 510515, China.

Hiroki TakigawaDepartment of Microbiology, Osaka Dental University, Hirakata 573-1121, Japan.

Hugo MaruyamaDepartment of Microbiology, Osaka Dental University, Hirakata 573-1121, Japan.ORCID 0000-0002-2190-7109

Chiho MashimoDepartment of Microbiology, Osaka Dental University, Hirakata 573-1121, Japan.

Toshinori OkinagaDepartment of Microbiology, Osaka Dental University, Hirakata 573-1121, Japan.

Funding

Japan Society for the Promotion of Science 20K10285, 23K09472, 21K10245, 19K10456, 23K09518, 22K09954SBI Pharmaceuticals (Japan) to T.N. and T.O.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aminolevulinic AcidFusobacterium nucleatumPhotochemotherapyPhotosensitizing AgentsRed LightAnti-Bacterial AgentsBiofilmsFusobacterium InfectionsHumansMicrobial ViabilityPorphyrinsAminolevulinic AcidAnti-Bacterial AgentsPhotosensitizing AgentsPorphyrins5-aminolevulinic acidFusobacterium nucleatumphotodynamic therapyred light-emitting diodesubspecies

Identifiers

PMID39599569

DOI10.3390/pathogens13111016

PMCPMC11597717

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.